Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution
According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bausch & Lomb
Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
Lupin Appoints Johnny Mikell as Global Head of Quality
Johnny will be based out of Lupin’s US offices and will lead the Company’s Quality function globally
Alembic Pharma gets US FDA nod for ophthalmic solution
The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 per cent,…